ARCHIVES

Phase III PANORAMA-1 Trial Meets PFS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Fake Avastin, Paid for by Medicare, Administered to U.S. Patients

October 3, 2014

Basic Research Group Seeks $7.9 Billion For NIH, $1.7 For NCI

July 24, 1987

60-Mile Limit For Primate Facility Dropped

June 9, 1978

NCI’s Richard Kaplan named associate director, National Cancer Research Network of UK.

January 2, 2004

Only 20 Percent Of At-Risk Patients Are Screened For HBV Before Therapy

November 25, 2011

Lung Cancer Survivors Claim Good QOL, Despite Challenges

August 30, 2002